Singapore: Australian drug delivery technology company, Phosphagenics, will be returning to the clinic with its oxycodo...
Singapore: An extensive study commissioned by Polycom, a global service provider, highlighted that lack of funding and g...
Singapore: Australia based pharmacuetical company, Starpharma, has appointed Mr Robert Thomas to the Board as a non-exec...
Singapore: Australia's Balnaves Foundation has donated $450,000 to the University of Sydney's medical school to help pro...
Singapore: Australian biopharmaceutical company, Specialised Therapeutics Australia (STA), and Helsinn, a Swiss group fo...
Singapore: A study conducted by Australian researchers from the Western Australian Institute for Medical Research (WAIMR...
Singapore: US based Celgene Corporation, a global biopharmaceutical, has agreed to acquire shares of Australia's regener...
Singapore: Leading nucleic acid-based drug discovery and development firm Marina Biotech has announced a worldwide expan...
Singapore: Australian scientists have confirmed a 'weak link' in the immune system, identifying the exact conditions und...
Singapore: A 12 member Australian Life sciences & Health care delegation is visiting India from 15 to 19 September t...
Singapore: Phase II clinical trials by scientists from the National Institute of Allergy and Infectious Diseases (NIAID)...
Singapore: Australia's National Health and Medical Research Council (NHMRC) has taken up the task of implementing initia...
Singapore: An 82-year-old prostate cancer patient has become the first person in Australia to be treated using the fast ...
Singapore: As per a recent news report, an Australian traveler to Japan has been diagnosed with dengue fever. As per the...
Singapore: New Zealand-based cancer diagnostic specialist Pacific Edge has completed the first commercial sales of Cxbla...
Singapore: Medtronic announced the submission of its first pre-market approval (PMA) module to the US Food and Drug Admi...
Sydney-headquartered Regeneus announced the completion of enrolment of all 20 patients in the STEP trial. Further, a rev...
In 2011, the Bill & Melinda Gates Foundation rolled out a new grant of $31 million to fund innovation in point-of-ca...
